$203.382,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

This issue of Rheumatic Disease Clinics, guest edited by Dr. John Davis, will discuss Cancer and Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: rheumatic drugs and malignancy potential, biologic drugs and cancer, methotrexate and cancer, managing rheumatoid arthritis with cancer, Sjogren’s Syndrome and cancer, lupus and cancer, scleroderma and cancer, cancer and spondylarthritis, and cancer immunotherapy.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Rheumatic Disease Clinics of North America - p. x 7. Foreword - p. xi 8. Preface - p. xiii 9. Overview of the Associations Between Cancer and Rheumatic Disease - p. 417 10. Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms - p. 429 11. Cancer and Rheumatoid Arthritis - p. 445 12. Risk of Malignancy in Spondyloarthritis: A Systematic Review - p. 463 13. Sjögren Syndrome and Cancer - p. 513 14. Cancer and Systemic Lupus Erythematosus - p. 533 15. Cancer and Scleroderma - p. 551 16. Risk Factors and Cancer Screening in Myositis - p. 565 17. Paraneoplastic Musculoskeletal Syndromes - p. 577 18. Immune Checkpoint Inhibition—Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity - p. 587

Descripcion
Descripción

This issue of Rheumatic Disease Clinics, guest edited by Dr. John Davis, will discuss Cancer and Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: rheumatic drugs and malignancy potential, biologic drugs and cancer, methotrexate and cancer, managing rheumatoid arthritis with cancer, Sjogren’s Syndrome and cancer, lupus and cancer, scleroderma and cancer, cancer and spondylarthritis, and cancer immunotherapy.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Rheumatic Disease Clinics of North America - p. x 7. Foreword - p. xi 8. Preface - p. xiii 9. Overview of the Associations Between Cancer and Rheumatic Disease - p. 417 10. Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms - p. 429 11. Cancer and Rheumatoid Arthritis - p. 445 12. Risk of Malignancy in Spondyloarthritis: A Systematic Review - p. 463 13. Sjögren Syndrome and Cancer - p. 513 14. Cancer and Systemic Lupus Erythematosus - p. 533 15. Cancer and Scleroderma - p. 551 16. Risk Factors and Cancer Screening in Myositis - p. 565 17. Paraneoplastic Musculoskeletal Syndromes - p. 577 18. Immune Checkpoint Inhibition—Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity - p. 587

Indice
Autores
Muestra
Ficha Técnica